Global Psoriasis Therapeutics Market Size study & Forecast, by Drug Class (TNF Inhibitors, PDE4 Inhibitors, Interleukin Blockers, and Others), Molecule Type (Biologics, and Small Molecules), and by Route of Administration (Oral, Parenteral, and Topical) and Regional Analysis, 2022-2029
Global Psoriasis Therapeutics Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Psoriasis is a type of skin disorders which causes skins cells to replace more quickly than normal. Psoriasis is associated with immune system and most commonly occurs on knees, elbows, trunk, and scalp. The increasing incidences of Psoriasis disease and rising awareness towards different treatment options available as well as strategic initiatives from leading market players are key factors accelerating the market growth.
According to National Psoriasis Foundation, USA – as of 2020, around 8 million individuals in the United States are affected by Psoriasis. In addition, around 125 million people worldwide suffers from Psoriasis, witnessing for over 2 to 3 percent of the global population. Moreover, as per World Health Organization (WHO) estimates – approximately 100 million individuals worldwide are affected by Psoriasis. Also, rising healthcare infrastructure in emerging economies and increasing R&D activities in pharmaceuticals sector would create lucrative growth prospectus for the market over the forecast period. However, high treatment cost associated with Psoriasis treatment and health risks associated with medications impede the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Psoriasis Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the; leading region in terms of market share owing to presence of leading market players as well as increasing prevalence of Psoriasis in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising pharmaceuticals sector as well as increasing incidences of skin disorders in the region.
Major market player included in this report are:
Astellas Pharma Inc.
AstraZeneca plc
Boehringer Ingelheim GmbH
F. Hofffmann-La Roche
GlaxoSmithKline plc
Merck and Co., Inc.
Valeant Pharmaceuticals International, Inc.
Biocon Limited
Eli Lilly and Company
G and W Laboratories Inc.
Recent Developments in the Market:
In October 2021, India based Sun Pharmaceuticals Ltd. unveiled its medicine named ILUMYA for the treatment of adults with moderate-to-severe plaque psoriasis in Canada.
In December 2021, The Food and Drug Administration of USA has approved the expanded use of Amgen Inc's drug Otezla for the treatment of adults with mild to moderate plaque psoriasis. With this approval Otezla would be the first and only oral treatment option available for plaque psoriasis in adults.
Global Psoriasis Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Molecule Type, Route of Administration, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others
By Molecule Type
Biologics
Small Molecules
By Route of Administration
Oral
Parenteral
Topical
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
According to National Psoriasis Foundation, USA – as of 2020, around 8 million individuals in the United States are affected by Psoriasis. In addition, around 125 million people worldwide suffers from Psoriasis, witnessing for over 2 to 3 percent of the global population. Moreover, as per World Health Organization (WHO) estimates – approximately 100 million individuals worldwide are affected by Psoriasis. Also, rising healthcare infrastructure in emerging economies and increasing R&D activities in pharmaceuticals sector would create lucrative growth prospectus for the market over the forecast period. However, high treatment cost associated with Psoriasis treatment and health risks associated with medications impede the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Psoriasis Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the; leading region in terms of market share owing to presence of leading market players as well as increasing prevalence of Psoriasis in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising pharmaceuticals sector as well as increasing incidences of skin disorders in the region.
Major market player included in this report are:
Astellas Pharma Inc.
AstraZeneca plc
Boehringer Ingelheim GmbH
F. Hofffmann-La Roche
GlaxoSmithKline plc
Merck and Co., Inc.
Valeant Pharmaceuticals International, Inc.
Biocon Limited
Eli Lilly and Company
G and W Laboratories Inc.
Recent Developments in the Market:
In October 2021, India based Sun Pharmaceuticals Ltd. unveiled its medicine named ILUMYA for the treatment of adults with moderate-to-severe plaque psoriasis in Canada.
In December 2021, The Food and Drug Administration of USA has approved the expanded use of Amgen Inc's drug Otezla for the treatment of adults with mild to moderate plaque psoriasis. With this approval Otezla would be the first and only oral treatment option available for plaque psoriasis in adults.
Global Psoriasis Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Molecule Type, Route of Administration, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others
By Molecule Type
Biologics
Small Molecules
By Route of Administration
Oral
Parenteral
Topical
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Psoriasis Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Psoriasis Therapeutics Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Psoriasis Therapeutics Market, by Molecule Type, 2019-2029 (USD Billion)
1.2.4. Psoriasis Therapeutics Market, by Route of Administration, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PSORIASIS THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PSORIASIS THERAPEUTICS MARKET DYNAMICS
3.1. Psoriasis Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of Psoriasis disease.
3.1.1.2. Rising awareness towards different treatment options available.
3.1.1.3. Strategic initiatives from leading market players.
3.1.2. Market Challenges
3.1.2.1. High treatment cost associated with Psoriasis treatment.
3.1.2.2. Health risks associated with medications.
3.1.3. Market Opportunities
3.1.3.1. Rising healthcare infrastructure in emerging economies.
3.1.3.2. Increasing R&D activities in pharmaceuticals sector.
CHAPTER 4. GLOBAL PSORIASIS THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL PSORIASIS THERAPEUTICS MARKET, BY DRUG CLASS
6.1. Market Snapshot
6.2. Global Psoriasis Therapeutics Market by Drug Class, Performance - Potential Analysis
6.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Psoriasis Therapeutics Market, Sub Segment Analysis
6.4.1. TNF Inhibitors
6.4.2. PDE4 Inhibitors
6.4.3. Interleukin Blockers
6.4.4. Others
CHAPTER 7. GLOBAL PSORIASIS THERAPEUTICS MARKET, BY MOLECULE TYPE
7.1. Market Snapshot
7.2. Global Psoriasis Therapeutics Market by Molecule Type, Performance - Potential Analysis
7.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Molecule Type 2019-2029 (USD Billion)
7.4. Psoriasis Therapeutics Market, Sub Segment Analysis
7.4.1. Biologics
7.4.2. Small Molecules
CHAPTER 8. GLOBAL PSORIASIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION
8.1. Market Snapshot
8.2. Global Psoriasis Therapeutics Market by Route of Administration, Performance - Potential Analysis
8.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
8.4. Psoriasis Therapeutics Market, Sub Segment Analysis
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Topical
CHAPTER 9. GLOBAL PSORIASIS THERAPEUTICS MARKET, REGIONAL ANALYSIS
9.1. Psoriasis Therapeutics Market, Regional Market Snapshot
9.2. North America Psoriasis Therapeutics Market
9.2.1. U.S. Psoriasis Therapeutics Market
9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
9.2.1.2. Molecule Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. Route of Administration breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Psoriasis Therapeutics Market
9.3. Europe Psoriasis Therapeutics Market Snapshot
9.3.1. U.K. Psoriasis Therapeutics Market
9.3.2. Germany Psoriasis Therapeutics Market
9.3.3. France Psoriasis Therapeutics Market
9.3.4. Spain Psoriasis Therapeutics Market
9.3.5. Italy Psoriasis Therapeutics Market
9.3.6. Rest of Europe Psoriasis Therapeutics Market
9.4. Asia-Pacific Psoriasis Therapeutics Market Snapshot
9.4.1. China Psoriasis Therapeutics Market
9.4.2. India Psoriasis Therapeutics Market
9.4.3. Japan Psoriasis Therapeutics Market
9.4.4. Australia Psoriasis Therapeutics Market
9.4.5. South Korea Psoriasis Therapeutics Market
9.4.6. Rest of Asia Pacific Psoriasis Therapeutics Market
9.5. Latin America Psoriasis Therapeutics Market Snapshot
9.5.1. Brazil Psoriasis Therapeutics Market
9.5.2. Mexico Psoriasis Therapeutics Market
9.6. Rest of The World Psoriasis Therapeutics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Astellas Pharma Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. AstraZeneca plc
10.2.3. Boehringer Ingelheim GmbH
10.2.4. F. Hofffmann-La Roche
10.2.5. GlaxoSmithKline plc
10.2.6. Merck and Co., Inc.
10.2.7. Valeant Pharmaceuticals International, Inc.
10.2.8. Biocon Limited
10.2.9. Eli Lilly and Company
10.2.10. G and W Laboratories Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Psoriasis Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Psoriasis Therapeutics Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Psoriasis Therapeutics Market, by Molecule Type, 2019-2029 (USD Billion)
1.2.4. Psoriasis Therapeutics Market, by Route of Administration, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL PSORIASIS THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL PSORIASIS THERAPEUTICS MARKET DYNAMICS
3.1. Psoriasis Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of Psoriasis disease.
3.1.1.2. Rising awareness towards different treatment options available.
3.1.1.3. Strategic initiatives from leading market players.
3.1.2. Market Challenges
3.1.2.1. High treatment cost associated with Psoriasis treatment.
3.1.2.2. Health risks associated with medications.
3.1.3. Market Opportunities
3.1.3.1. Rising healthcare infrastructure in emerging economies.
3.1.3.2. Increasing R&D activities in pharmaceuticals sector.
CHAPTER 4. GLOBAL PSORIASIS THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL PSORIASIS THERAPEUTICS MARKET, BY DRUG CLASS
6.1. Market Snapshot
6.2. Global Psoriasis Therapeutics Market by Drug Class, Performance - Potential Analysis
6.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Psoriasis Therapeutics Market, Sub Segment Analysis
6.4.1. TNF Inhibitors
6.4.2. PDE4 Inhibitors
6.4.3. Interleukin Blockers
6.4.4. Others
CHAPTER 7. GLOBAL PSORIASIS THERAPEUTICS MARKET, BY MOLECULE TYPE
7.1. Market Snapshot
7.2. Global Psoriasis Therapeutics Market by Molecule Type, Performance - Potential Analysis
7.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Molecule Type 2019-2029 (USD Billion)
7.4. Psoriasis Therapeutics Market, Sub Segment Analysis
7.4.1. Biologics
7.4.2. Small Molecules
CHAPTER 8. GLOBAL PSORIASIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION
8.1. Market Snapshot
8.2. Global Psoriasis Therapeutics Market by Route of Administration, Performance - Potential Analysis
8.3. Global Psoriasis Therapeutics Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
8.4. Psoriasis Therapeutics Market, Sub Segment Analysis
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Topical
CHAPTER 9. GLOBAL PSORIASIS THERAPEUTICS MARKET, REGIONAL ANALYSIS
9.1. Psoriasis Therapeutics Market, Regional Market Snapshot
9.2. North America Psoriasis Therapeutics Market
9.2.1. U.S. Psoriasis Therapeutics Market
9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
9.2.1.2. Molecule Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. Route of Administration breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Psoriasis Therapeutics Market
9.3. Europe Psoriasis Therapeutics Market Snapshot
9.3.1. U.K. Psoriasis Therapeutics Market
9.3.2. Germany Psoriasis Therapeutics Market
9.3.3. France Psoriasis Therapeutics Market
9.3.4. Spain Psoriasis Therapeutics Market
9.3.5. Italy Psoriasis Therapeutics Market
9.3.6. Rest of Europe Psoriasis Therapeutics Market
9.4. Asia-Pacific Psoriasis Therapeutics Market Snapshot
9.4.1. China Psoriasis Therapeutics Market
9.4.2. India Psoriasis Therapeutics Market
9.4.3. Japan Psoriasis Therapeutics Market
9.4.4. Australia Psoriasis Therapeutics Market
9.4.5. South Korea Psoriasis Therapeutics Market
9.4.6. Rest of Asia Pacific Psoriasis Therapeutics Market
9.5. Latin America Psoriasis Therapeutics Market Snapshot
9.5.1. Brazil Psoriasis Therapeutics Market
9.5.2. Mexico Psoriasis Therapeutics Market
9.6. Rest of The World Psoriasis Therapeutics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Astellas Pharma Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. AstraZeneca plc
10.2.3. Boehringer Ingelheim GmbH
10.2.4. F. Hofffmann-La Roche
10.2.5. GlaxoSmithKline plc
10.2.6. Merck and Co., Inc.
10.2.7. Valeant Pharmaceuticals International, Inc.
10.2.8. Biocon Limited
10.2.9. Eli Lilly and Company
10.2.10. G and W Laboratories Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Psoriasis Therapeutics Market, report scope
TABLE 2. Global Psoriasis Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Psoriasis Therapeutics Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Psoriasis Therapeutics Market estimates & forecasts by Molecule Type 2019-2029 (USD Billion)
TABLE 5. Global Psoriasis Therapeutics Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
TABLE 6. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Psoriasis Therapeutics Market
TABLE 71. List of primary sources, used in the study of global Psoriasis Therapeutics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Psoriasis Therapeutics Market, report scope
TABLE 2. Global Psoriasis Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Psoriasis Therapeutics Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Psoriasis Therapeutics Market estimates & forecasts by Molecule Type 2019-2029 (USD Billion)
TABLE 5. Global Psoriasis Therapeutics Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
TABLE 6. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Psoriasis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Psoriasis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Psoriasis Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Psoriasis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Psoriasis Therapeutics Market
TABLE 71. List of primary sources, used in the study of global Psoriasis Therapeutics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Psoriasis Therapeutics Market, research methodology
FIG 2. Global Psoriasis Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Psoriasis Therapeutics Market, key trends 2021
FIG 5. Global Psoriasis Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Psoriasis Therapeutics Market, porters 5 force model
FIG 7. Global Psoriasis Therapeutics Market, pest analysis
FIG 8. Global Psoriasis Therapeutics Market, value chain analysis
FIG 9. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Psoriasis Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
FIG 19. Global Psoriasis Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Psoriasis Therapeutics Market, research methodology
FIG 2. Global Psoriasis Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Psoriasis Therapeutics Market, key trends 2021
FIG 5. Global Psoriasis Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Psoriasis Therapeutics Market, porters 5 force model
FIG 7. Global Psoriasis Therapeutics Market, pest analysis
FIG 8. Global Psoriasis Therapeutics Market, value chain analysis
FIG 9. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Psoriasis Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Psoriasis Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Psoriasis Therapeutics Market 2019 & 2029 (USD Billion)
FIG 19. Global Psoriasis Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
